Award ID: 75H71225F28019
| Mod # | Date | Amount | Action Type | Description |
|---|---|---|---|---|
| — | Apr 3, 2026 | $400K | Bpa call against 75h71221a00002, siemens. | |
| — | Jun 16, 2025 | $800K | Bpa call against 75h71221a00002, siemens. | |
| — | Apr 11, 2025 | $17K | Order for blood products | |
| — | Mar 14, 2025 | $500K | Cepheid, wrsu | |
| — | Dec 10, 2024 | $22K | Rqi, hhcc |
This contract was awarded to SIEMENS HEALTHCARE DIAGNOSTICS INC. (based in Massachusetts) by Department of Health and Human Services, specifically the Indian Health Service sub-agency. The award represents one of millions of federal procurement actions tracked through USASpending.gov, the official source of federal spending data.
The obligated amount is $400,000, with a total contract ceiling of $1,200,000. Federal contract obligations represent funds committed by the government for goods or services. Actual outlays may differ if contract modifications, terminations, or scope changes occur during the period of performance.
This contract is classified under NAICS code 325413 — In-Vitro Diagnostic Substance Manufacturing. The North American Industry Classification System (NAICS) is used by federal agencies to categorize establishments by their primary business activity. Browse all federal contracts under NAICS 325413 to compare similar awards by amount, agency, and recipient.
The place of performance for this contract is Arizona, specifically in or around PHOENIX. Federal contracts are distributed across all 50 states, with concentrations in defense corridors and metropolitan areas hosting major federal facilities.